10-Deacetylbaccatin III Market to Hit USD 236M by 2032 at 5.5% CAGR
10‑Deacetylbaccatin III Market — Strategic Outlook for 2026 Decision‑Making Executive snapshot The global market for 10‑Deacetylbaccatin III (10‑DAB III), a critical botanical intermediate used in the semi‑synthesis of taxane oncology drugs, has exhibited steady expansion over the first half of …